| scholarly article | Q13442814 |
| P2093 | author name string | Shan Li | |
| Hong Wang | |||
| Xiao-Feng Yang | |||
| Eric T Choi | |||
| M Alexandra Monroy | |||
| Jianhua Fang | |||
| Lucas Ferrer | |||
| Iris J Lee | |||
| Mark P Birkenbach | |||
| P2860 | cites work | Translating the Histone Code | Q22065840 |
| Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin | Q24311484 | ||
| Chromatin modifications and their function | Q27861067 | ||
| Endoplasmic reticulum stress and atherosclerosis | Q28279152 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
| Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. | Q30306339 | ||
| Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms | Q30421700 | ||
| Regulation of differentiation of vascular smooth muscle cells | Q30464387 | ||
| Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility | Q34782136 | ||
| Severe venous neointimal hyperplasia prior to dialysis access surgery | Q35133067 | ||
| The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. | Q37074430 | ||
| CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas | Q37211143 | ||
| Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis | Q37393223 | ||
| Does uremia cause vascular dysfunction? | Q37892318 | ||
| Vascular access in haemodialysis: strengthening the Achilles' heel | Q38099516 | ||
| The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells | Q39708948 | ||
| The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency | Q40495060 | ||
| Intimal changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction | Q40541416 | ||
| Smooth muscle migration in vascular development and pathogenesis | Q41721738 | ||
| Chronic kidney disease aggravates arteriovenous fistula damage in rats | Q42873295 | ||
| Hemodialysis vascular access morbidity. | Q50106048 | ||
| Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. | Q50701648 | ||
| EBPG on Vascular Access. | Q51002285 | ||
| Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture | Q58040344 | ||
| Pathobiology of intimal hyperplasia | Q72787481 | ||
| Ultrasonographic measurement of intima-media thickness of radial artery in pre-dialysis uraemic patients: comparison with histological examination | Q81402266 | ||
| Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions | Q82979129 | ||
| Cardiovascular mortality in the general population versus dialysis: a glass half full or empty? | Q84388680 | ||
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 784-795 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | Chronic kidney disease alters vascular smooth muscle cell phenotype | |
| P478 | volume | 20 |
| Q37461331 | Caspase-1 Plays a Critical Role in Accelerating Chronic Kidney Disease-Promoted Neointimal Hyperplasia in the Carotid Artery |
| Q93368983 | Co-signaling receptors regulate T-cell plasticity and immune tolerance |
| Q90366970 | End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression |
| Q49682985 | IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14). |
| Q64102493 | Increasing Upstream Chromatin Long-Range Interactions May Favor Induction of Circular RNAs in LysoPC-Activated Human Aortic Endothelial Cells |
| Q36228307 | Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice |
| Q88698381 | Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation |
| Q42054472 | New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes |
| Q50300037 | Phenotypic Modulation of Cultured Primary Human Aortic Vascular Smooth Muscle Cells by Uremic Serum. |
| Q40834381 | Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes |
| Q55515015 | The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function. |
| Q57296687 | Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions |
| Q41140912 | Uremia does not affect neointima formation in mice |
| Q49992231 | Uremic toxins are conditional danger- or homeostasis-associated molecular patterns. |
Search more.